IPS HEART
PrivateLast Round
Accelerator
Jun 19, 2018
Company Overview
IPS HEART is a biopharmaceutical company that develops stem cell therapies to treat heart failure, Duchenne muscular dystrophy, and other cardiac and muscular disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IPS HEART Comparables
Compare IPS HEART with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vita Therapeutics | 83% | |
| Avery Therapeutics, Inc. | 82% | |
| Myogenica, Inc. | 82% |
IPS HEART Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 19, 2018 |
IPS HEART Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Johnson & Johnson Innovation - JLABS | Accelerator |
IPS HEART Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about IPS HEART's valuation, stock price, and market status.
Is IPS HEART a public or private company?
IPS HEART is a private company.
What is the current stock price of IPS HEART?
IPS HEART is a private company, so its shares have no public market price. Caplight tracks IPS HEART's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is IPS HEART worth (valuation)?
Valuation information for IPS HEART is not publicly available.
Can I buy IPS HEART stock?
IPS HEART shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was IPS HEART's last funding round?
IPS HEART's most recent funding round was Accelerator on June 19, 2018.
Who are the main investors in IPS HEART?
Key investors in IPS HEART include Johnson & Johnson Innovation - JLABS.
Will IPS HEART IPO soon?
No public IPO plans have been announced for IPS HEART.
How can I track IPS HEART secondary market activity?
Caplight tracks bids, offers, and trades in IPS HEART's shares on secondary markets.